Radius Health, Inc. (RDUS) Falls on Delay in US Drug Application
November 18, 2015 at 08:35 AM EST
Shares of Cambridge, Massachusetts, based Radius Health, Inc. (RDUS) fell on Tuesday, against the backrop of a mixed day in stocks overall. Radius Health's stock was down 11.09%, falling $7.67 per share, to close at $61.51, on volume of 2,540,166 shares. The company's anti-osteoporosus drug has been filed for approval in Europe, but will be ... READ MORE Read the rest of Radius Health, Inc. (RDUS) Falls on Delay in US Drug Application at InvestorGuide.com .
